The goal of this randomised clinical trial is to investigate the effectiveness of an innovative therapeutic exercise program emphasizing in dual-task exercises in people with amnestic Mild Cognitive Impairment. The main questions it aims to answer are: Does the innovative therapeutic exercise program improve gait and balance? Does the innovative therapeutic exercise program improve cognition? Researchers will compare the innovative therapeutic exercise program emphasizing in dual-task exercises to a therapeutic exercise program without emphasizing in dual-task exercises and to a control group (given instruction about the benefits of exercise). Participants will: * Perform the exercise program twice a week for three months. * Will be assessed before and after the intervention. * Will record The Borg Scale of Perceived Exertion every second week to monitor and assess the progression of exercise intensity.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Kinematic and kinetic gait assessment
Timeframe: baseline, post- intervention (12 weeks)
Functional Gait Assessment (FGA)
Timeframe: baseline, post- intervention (12 weeks)
mini Balance Evaluation Systems Test (mini-BESTest)
Timeframe: baseline, post- intervention (12 weeks)
Montreal Cognitive Assessment (MoCA)
Timeframe: baseline, post- intervention (12 weeks)
Cognitive Telephone Screening Instrument (COGTEL)
Timeframe: baseline, post- intervention (12 weeks)
Stroop Test
Timeframe: baseline, post- intervention (12 weeks)